| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Galera Therapeutics Inc (NASDAQ: GRTX)
GRTX Technical Analysis
3
| As on 9th Jun 2023 GRTX STOCK Price closed @ 3.23 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.97 & Buy for SHORT-TERM with Stoploss of 2.99 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GRTXSTOCK Price
| Open | 3.04 | Change | Price | % |
| High | 3.26 | 1 Day | 0.22 | 7.31 |
| Low | 3.02 | 1 Week | 0.16 | 5.21 |
| Close | 3.23 | 1 Month | 0.55 | 20.52 |
| Volume | 436000 | 1 Year | -0.56 | -14.78 |
| 52 Week High 5.05 | 52 Week Low 1.15 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| GRTX Daily Charts |
GRTX Intraday Charts |
Whats New @ Bazaartrend |
GRTX Free Analysis |
|
|
GRTX Important Levels Intraday
| RESISTANCE | 3.69 |
| RESISTANCE | 3.54 |
| RESISTANCE | 3.45 |
| RESISTANCE | 3.36 |
| SUPPORT | 3.10 |
| SUPPORT | 3.01 |
| SUPPORT | 2.92 |
| SUPPORT | 2.77 |
GRTX Forecast May 2024
| 4th UP Forecast | 6.49 |
| 3rd UP Forecast | 5.44 |
| 2nd UP Forecast | 4.8 |
| 1st UP Forecast | 4.15 |
| 1st DOWN Forecast | 2.31 |
| 2nd DOWN Forecast | 1.66 |
| 3rd DOWN Forecast | 1.02 |
| 4th DOWN Forecast | -0.03 |
GRTX Weekly Forecast
| 4th UP Forecast | 6.04 |
| 3rd UP Forecast | 5.14 |
| 2nd UP Forecast | 4.58 |
| 1st UP Forecast | 4.03 |
| 1st DOWN Forecast | 2.43 |
| 2nd DOWN Forecast | 1.88 |
| 3rd DOWN Forecast | 1.32 |
| 4th DOWN Forecast | 0.42 |
GRTX Forecast2024
| 4th UP Forecast | 11.46 |
| 3rd UP Forecast | 8.82 |
| 2nd UP Forecast | 7.19 |
| 1st UP Forecast | 5.56 |
| 1st DOWN Forecast | 0.9 |
| 2nd DOWN Forecast | -0.73 |
| 3rd DOWN Forecast | -2.36 |
| 4th DOWN Forecast | -5 |
Galera Therapeutics Inc ( NASDAQ USA Symbol : GRTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GRTX Business Profile
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which is in Phase III clinical trial for the treatment of radiation-induced severe oral mucositis in patients with head and neck cancer (HNC); and in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; in phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy; and has completed pilot placebo-controlled Phase I/II clinical trial in combination with stereotactic body radiation therapy (SBRT) for patients with locally advanced pancreatic cancer, as well as in Phase II clinical trial for hospitalized patients with COVID-19 disease. It is also involved in developing GC4711, a superoxide dismutase mimetic product candidate, which is in Phase I/II clinical trial in combination with SBRT in patients with non-small cell lung cancer. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. Address: 2 West Liberty Boulevard, Malvern, PA, United States, 19355
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service